Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Intra-cavity stem cell therapy inhibits tumor progression in a novel murine model of medulloblastoma surgical resection.

Okolie O, Irvin DM, Bago JR, Sheets K, Satterlee A, Carey-Ewend AG, Lettry V, Dumitru R, Elton S, Ewend MG, Miller CR, Hingtgen SD.

PLoS One. 2018 Jul 10;13(7):e0198596. doi: 10.1371/journal.pone.0198596. eCollection 2018.

2.

PIK3CA missense mutations promote glioblastoma pathogenesis, but do not enhance targeted PI3K inhibition.

McNeill RS, Stroobant EE, Smithberger E, Canoutas DA, Butler MK, Shelton AK, Patel SD, Limas JC, Skinner KR, Bash RE, Schmid RS, Miller CR.

PLoS One. 2018 Jul 5;13(7):e0200014. doi: 10.1371/journal.pone.0200014. eCollection 2018.

3.

A randomized controlled trial to determine whether a video presentation improves informed consent for hysterectomy.

Pallett AC, Nguyen B, Klein NM, Phippen N, Miller CR, Barnett JC.

Am J Obstet Gynecol. 2018 Jun 27. pii: S0002-9378(18)30532-5. doi: 10.1016/j.ajog.2018.06.016. [Epub ahead of print]

PMID:
29959929
4.

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases.

Van Swearingen AED, Siegel MB, Deal AM, Sambade MJ, Hoyle A, Hayes DN, Jo H, Little P, Dees EC, Muss H, Jolly T, Zagar TM, Patel N, Miller CR, Parker JS, Smith JK, Fisher J, Shah N, Nabell L, Nanda R, Dillon P, Abramson V, Carey LA, Anders CK.

Breast Cancer Res Treat. 2018 Jun 25. doi: 10.1007/s10549-018-4852-5. [Epub ahead of print]

PMID:
29938395
5.

Bill size variation in northern cardinals associated with anthropogenic drivers across North America.

Miller CR, Latimer CE, Zuckerberg B.

Ecol Evol. 2018 Apr 17;8(10):4841-4851. doi: 10.1002/ece3.4038. eCollection 2018 May.

6.

Management of highly differentiated thyroid follicular carcinoma of ovarian origin with a minimally invasive approach.

Riggs MJ, Kluesner JK, Miller CR.

Gynecol Oncol Rep. 2018 Apr 19;24:87-89. doi: 10.1016/j.gore.2018.04.008. eCollection 2018 May.

7.

Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma.

Kesarwani P, Prabhu A, Kant S, Kumar P, Graham SF, Buelow KL, Wilson GD, Miller CR, Chinnaiyan P.

Clin Cancer Res. 2018 Apr 24. doi: 10.1158/1078-0432.CCR-18-0041. [Epub ahead of print]

PMID:
29691296
8.

Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling.

Danussi C, Bose P, Parthasarathy PT, Silberman PC, Van Arnam JS, Vitucci M, Tang OY, Heguy A, Wang Y, Chan TA, Riggins GJ, Sulman EP, Lang F, Creighton CJ, Deneen B, Miller CR, Picketts DJ, Kannan K, Huse JT.

Nat Commun. 2018 Mar 13;9(1):1057. doi: 10.1038/s41467-018-03476-6.

9.

Frequency of breast cancer subtypes among African American women in the AMBER consortium.

Allott EH, Geradts J, Cohen SM, Khoury T, Zirpoli GR, Bshara W, Davis W, Omilian A, Nair P, Ondracek RP, Cheng TD, Miller CR, Hwang H, Thorne LB, O'Connor S, Bethea TN, Bell ME, Hu Z, Li Y, Kirk EL, Sun X, Ruiz-Narvaez EA, Perou CM, Palmer JR, Olshan AF, Ambrosone CB, Troester MA.

Breast Cancer Res. 2018 Feb 6;20(1):12. doi: 10.1186/s13058-018-0939-5.

10.

Cross-species transcriptional analysis reveals conserved and host-specific neoplastic processes in mammalian glioma.

Connolly NP, Shetty AC, Stokum JA, Hoeschele I, Siegel MB, Miller CR, Kim AJ, Ho CY, Davila E, Simard JM, Devine SE, Rossmeisl JH, Holland EC, Winkles JA, Woodworth GF.

Sci Rep. 2018 Jan 19;8(1):1180. doi: 10.1038/s41598-018-19451-6.

11.

Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection.

Graham-Gurysh E, Moore KM, Satterlee AB, Sheets KT, Lin FC, Bachelder EM, Miller CR, Hingtgen SD, Ainslie KM.

Mol Pharm. 2018 Mar 5;15(3):1309-1318. doi: 10.1021/acs.molpharmaceut.7b01114. Epub 2018 Feb 2.

12.

Comparison of the Alere i Strep A Test and the BD Veritor System in the Detection of Group A Streptococcus and the Hypothetical Impact of Results on Antibiotic Utilization.

Berry GJ, Miller CR, Prats MM, Marquez C, Oladipo OO, Loeffelholz MJ, Petersen JR.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01310-17. doi: 10.1128/JCM.01310-17. Print 2018 Mar.

PMID:
29305539
13.

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.

Miller CR, Ruppert AS, Heerema NA, Maddocks KJ, Labanowska J, Breidenbach H, Lozanski G, Zhao W, Gordon AL, Jones JA, Flynn JM, Jaglowski SM, Andritsos LA, Blum KA, T Awan F, Rogers KA, Grever MR, Johnson AJ, Abruzzo LV, Hertlein EK, Blachly JS, Woyach JA, Byrd JC.

Blood Adv. 2017 Aug 21;1(19):1584-1588. doi: 10.1182/bloodadvances.2017007302. eCollection 2017 Aug 22.

14.

Selecting among three basic fitness landscape models: Additive, multiplicative and stickbreaking.

Miller CR, Van Leuven JT, Wichman HA, Joyce P.

Theor Popul Biol. 2018 Jul;122:97-109. doi: 10.1016/j.tpb.2017.10.006. Epub 2017 Dec 2.

PMID:
29198859
15.

Combined effects of night warming and light pollution on predator-prey interactions.

Miller CR, Barton BT, Zhu L, Radeloff VC, Oliver KM, Harmon JP, Ives AR.

Proc Biol Sci. 2017 Oct 11;284(1864). pii: 20171195. doi: 10.1098/rspb.2017.1195.

PMID:
29021171
16.

Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02.

Galanis E, Anderson SK, Miller CR, Sarkaria JN, Jaeckle K, Buckner JC, Ligon KL, Ballman KV, Moore DF Jr, Nebozhyn M, Loboda A, Schiff D, Ahluwalia MS, Lee EQ, Gerstner ER, Lesser GJ, Prados M, Grossman SA, Cerhan J, Giannini C, Wen PY; Alliance for Clinical Trials in Oncology and ABTC.

Neuro Oncol. 2018 Mar 27;20(4):546-556. doi: 10.1093/neuonc/nox161.

PMID:
29016887
17.

Putting "multiforme" back into glioblastoma: intratumoral transcriptome heterogeneity is a consequence of its complex morphology.

Khagi S, Miller CR.

Neuro Oncol. 2017 Nov 29;19(12):1570-1571. doi: 10.1093/neuonc/nox131. No abstract available.

PMID:
29016836
18.

Pharmacokinetics and efficacy of doxorubicin-loaded plant virus nanoparticles in preclinical models of cancer.

Madden AJ, Oberhardt B, Lockney D, Santos C, Vennam P, Arney D, Franzen S, Lommel SA, Miller CR, Gehrig P, Zamboni WC.

Nanomedicine (Lond). 2017 Oct;12(20):2519-2532. doi: 10.2217/nnm-2016-0421. Epub 2017 Sep 27.

PMID:
28952882
19.

Malignant solitary fibrous tumour of the kidney with lymph node and liver metastases: beware of STAT6 expression in dedifferentiated liposarcoma with a solitary fibrous tumour-like morphology: author reply.

Yang Y, Miller CR, Clement C, Hes O, Eyzaguirre E.

Pathology. 2017 Oct;49(6):671-672. doi: 10.1016/j.pathol.2017.07.005. Epub 2017 Aug 31. No abstract available.

PMID:
28838615
20.

The draft genome of the hyperthermophilic archaeon Pyrodictium delaneyi strain hulk, an iron and nitrate reducer, reveals the capacity for sulfate reduction.

Demey LM, Miller CR, Manzella MP, Spurbeck RR, Sandhu SK, Reguera G, Kashefi K.

Stand Genomic Sci. 2017 Aug 15;12:47. doi: 10.1186/s40793-017-0260-4. eCollection 2017.

21.

Prolonged viral replication and longitudinal viral dynamic differences among respiratory syncytial virus infected infants.

Brint ME, Hughes JM, Shah A, Miller CR, Harrison LG, Meals EA, Blanch J, Thompson CR, Cormier SA, DeVincenzo JP.

Pediatr Res. 2017 Nov;82(5):872-880. doi: 10.1038/pr.2017.173. Epub 2017 Aug 9.

22.

Pineal Region Glioblastoma, a Case Report and Literature Review.

Stowe HB, Miller CR, Wu J, Randazzo DM, Ju AW.

Front Oncol. 2017 Jun 12;7:123. doi: 10.3389/fonc.2017.00123. eCollection 2017.

23.

MerTK as a therapeutic target in glioblastoma.

Wu J, Frady LN, Bash RE, Cohen SM, Schorzman AN, Su YT, Irvin DM, Zamboni WC, Wang X, Frye SV, Ewend MG, Sulman EP, Gilbert MR, Earp HS, Miller CR.

Neuro Oncol. 2018 Jan 10;20(1):92-102. doi: 10.1093/neuonc/nox111.

PMID:
28605477
24.

Lung epithelial cells have virus-specific and shared gene expression responses to infection by diverse respiratory viruses.

VanLeuven JT, Ridenhour BJ, Gonzalez AJ, Miller CR, Miura TA.

PLoS One. 2017 Jun 2;12(6):e0178408. doi: 10.1371/journal.pone.0178408. eCollection 2017.

25.

The brain microenvironment mediates resistance in luminal breast cancer to PI3K inhibition through HER3 activation.

Kodack DP, Askoxylakis V, Ferraro GB, Sheng Q, Badeaux M, Goel S, Qi X, Shankaraiah R, Cao ZA, Ramjiawan RR, Bezwada D, Patel B, Song Y, Costa C, Naxerova K, Wong CSF, Kloepper J, Das R, Tam A, Tanboon J, Duda DG, Miller CR, Siegel MB, Anders CK, Sanders M, Estrada MV, Schlegel R, Arteaga CL, Brachtel E, Huang A, Fukumura D, Engelman JA, Jain RK.

Sci Transl Med. 2017 May 24;9(391). pii: eaal4682. doi: 10.1126/scitranslmed.aal4682.

26.

Combined kinase inhibitors of MEK1/2 and either PI3K or PDGFR are efficacious in intracranial triple-negative breast cancer.

Van Swearingen AED, Sambade MJ, Siegel MB, Sud S, McNeill RS, Bevill SM, Chen X, Bash RE, Mounsey L, Golitz BT, Santos C, Deal A, Parker JS, Rashid N, Miller CR, Johnson GL, Anders CK.

Neuro Oncol. 2017 Oct 19;19(11):1481-1493. doi: 10.1093/neuonc/nox052.

PMID:
28486691
27.

Malignant solitary fibrous tumour of the kidney with lymph node and liver metastases.

Yang Y, Miller CR, Clement C, Hes O, Eyzaguirre E.

Pathology. 2017 Jun;49(4):450-453. doi: 10.1016/j.pathol.2017.01.014. Epub 2017 Apr 25. No abstract available.

PMID:
28450090
28.

The long noncoding RNA, treRNA, decreases DNA damage and is associated with poor response to chemotherapy in chronic lymphocytic leukemia.

Miller CR, Ruppert AS, Fobare S, Chen TL, Liu C, Lehman A, Blachly JS, Zhang X, Lucas DM, Grever MR, Tallman MS, Flinn IW, Rassenti LZ, Kipps TJ, Sampath D, Coombes KR, Hertlein EK.

Oncotarget. 2017 Apr 18;8(16):25942-25954. doi: 10.18632/oncotarget.15401.

29.

Genomic profiles of low-grade murine gliomas evolve during progression to glioblastoma.

Vitucci M, Irvin DM, McNeill RS, Schmid RS, Simon JM, Dhruv HD, Siegel MB, Werneke AM, Bash RE, Kim S, Berens ME, Miller CR.

Neuro Oncol. 2017 Sep 1;19(9):1237-1247. doi: 10.1093/neuonc/nox050.

PMID:
28398584
30.

Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma.

McNeill RS, Canoutas DA, Stuhlmiller TJ, Dhruv HD, Irvin DM, Bash RE, Angus SP, Herring LE, Simon JM, Skinner KR, Limas JC, Chen X, Schmid RS, Siegel MB, Van Swearingen AED, Hadler MJ, Sulman EP, Sarkaria JN, Anders CK, Graves LM, Berens ME, Johnson GL, Miller CR.

Neuro Oncol. 2017 Oct 19;19(11):1469-1480. doi: 10.1093/neuonc/nox044.

PMID:
28379424
31.

Actinomyces-Related Tubo-Ovarian Abscess in a Poorly Controlled Type II Diabetic With a Copper Intrauterine Device.

Sawtelle AL, Chappell NP, Miller CR.

Mil Med. 2017 Mar;182(3):e1874-e1876. doi: 10.7205/MILMED-D-16-00228.

PMID:
28290977
32.

Tumor-homing cytotoxic human induced neural stem cells for cancer therapy.

Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD.

Sci Transl Med. 2017 Feb 1;9(375). pii: eaah6510. doi: 10.1126/scitranslmed.aah6510.

PMID:
28148846
33.

Liquid Biopsies in the Management of Bladder Cancer: Next-Generation Biomarkers for Diagnosis, Surveillance, and Treatment-Response Prediction.

Yang Y, Miller CR, Lopez-Beltran A, Montironi R, Cheng M, Zhang S, Koch MO, Kaimakliotis HZ, Cheng L.

Crit Rev Oncog. 2017;22(5-6):389-401. doi: 10.1615/CritRevOncog.2017020803.

PMID:
29604919
34.

Planning horizon affects prophylactic decision-making and epidemic dynamics.

Nardin LG, Miller CR, Ridenhour BJ, Krone SM, Joyce P, Baumgaertner BO.

PeerJ. 2016 Nov 8;4:e2678. doi: 10.7717/peerj.2678. eCollection 2016.

35.

Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174?

Miller CR, Chappell NP, Sledge C, Leath CA 3rd, Phippen NT, Havrilesky LJ, Barnett JC.

Gynecol Oncol. 2017 Jan;144(1):125-129. doi: 10.1016/j.ygyno.2016.10.038. Epub 2016 Nov 3.

36.

Comparative Evaluation of Potentially Radiolucent Projectile Components by Radiographs and Computed Tomography.

Miller CR, Haag M, Gerrard C, Hatch GM, Elifritz J, Simmons MC, Lathrop S, Nolte KB.

J Forensic Sci. 2016 Nov;61(6):1563-1570. doi: 10.1111/1556-4029.13225. Epub 2016 Oct 27.

PMID:
27787896
37.

Predicting the need for nonstandard tracheostomy tubes in critically ill patients.

Pandian V, Hutchinson CT, Schiavi AJ, Feller-Kopman DJ, Haut ER, Parsons NA, Lin JS, Gorbatkin C, Angamuthu PG, Miller CR, Mirski MA, Bhatti NI, Yarmus LB.

J Crit Care. 2017 Feb;37:173-178. doi: 10.1016/j.jcrc.2016.05.025. Epub 2016 Jun 4.

PMID:
27756050
38.

Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.

Blount RJ, Tran MC, Everett CK, Cattamanchi A, Metcalfe JZ, Connor D, Miller CR, Grinsdale J, Higashi J, Nahid P.

BMC Public Health. 2016 Aug 25;16(1):875. doi: 10.1186/s12889-016-3519-6.

39.

Love the one you're with: replicate viral adaptations converge on the same phenotypic change.

Miller CR, Nagel AC, Scott L, Settles M, Joyce P, Wichman HA.

PeerJ. 2016 Jul 19;4:e2227. doi: 10.7717/peerj.2227. eCollection 2016.

40.

BRAF Mutations Open Doors for N-Ethyl-N-Nitrosourea-Induced Gliomagenesis.

McNeill RS, Irvin DM, Miller CR.

Am J Pathol. 2016 Oct;186(10):2551-4. doi: 10.1016/j.ajpath.2016.07.005. Epub 2016 Aug 18.

41.

New Perspectives on Ebola Virus Evolution.

Brown CJ, Quates CJ, Mirabzadeh CA, Miller CR, Wichman HA, Miura TA, Ytreberg FM.

PLoS One. 2016 Aug 1;11(8):e0160410. doi: 10.1371/journal.pone.0160410. eCollection 2016.

42.

Reactive astrocytes potentiate tumor aggressiveness in a murine glioma resection and recurrence model.

Okolie O, Bago JR, Schmid RS, Irvin DM, Bash RE, Miller CR, Hingtgen SD.

Neuro Oncol. 2016 Dec;18(12):1622-1633. Epub 2016 Jun 13.

43.

Is FDA-Approved Bevacizumab Cost-Effective When Included in the Treatment of Platinum-Resistant Recurrent Ovarian Cancer?

Chappell NP, Miller CR, Fielden AD, Barnett JC.

J Oncol Pract. 2016 Jul;12(7):e775-83. doi: 10.1200/JOP.2015.010470. Epub 2016 May 31.

PMID:
27246689
44.

Obituary: Paul Joyce (1958-2016).

Miller CR, Wichman HA.

Biol Lett. 2016 May;12(5). pii: 20160396. doi: 10.1098/rsbl.2016.0396. No abstract available.

45.

Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.

LeBlanc AK, Mazcko C, Brown DE, Koehler JW, Miller AD, Miller CR, Bentley RT, Packer RA, Breen M, Boudreau CE, Levine JM, Simpson RM, Halsey C, Kisseberth W, Rossmeisl JH Jr, Dickinson PJ, Fan TM, Corps K, Aldape K, Puduvalli V, Pluhar GE, Gilbert MR.

Neuro Oncol. 2016 Sep;18(9):1209-18. doi: 10.1093/neuonc/now051. Epub 2016 May 14. Review.

46.

Initiating a watch list for Ebola virus antibody escape mutations.

Miller CR, Johnson EL, Burke AZ, Martin KP, Miura TA, Wichman HA, Brown CJ, Ytreberg FM.

PeerJ. 2016 Feb 16;4:e1674. doi: 10.7717/peerj.1674. eCollection 2016.

47.

Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174.

Baker CW, Miller CR, Thaweethai T, Yuan J, Baker MH, Joyce P, Weinreich DM.

G3 (Bethesda). 2016 Apr 7;6(4):939-55. doi: 10.1534/g3.115.024075.

48.

Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

Bagó JR, Alfonso-Pecchio A, Okolie O, Dumitru R, Rinkenbaugh A, Baldwin AS, Miller CR, Magness ST, Hingtgen SD.

Nat Commun. 2016 Feb 2;7:10593. doi: 10.1038/ncomms10593.

49.

Core pathway mutations induce de-differentiation of murine astrocytes into glioblastoma stem cells that are sensitive to radiation but resistant to temozolomide.

Schmid RS, Simon JM, Vitucci M, McNeill RS, Bash RE, Werneke AM, Huey L, White KK, Ewend MG, Wu J, Miller CR.

Neuro Oncol. 2016 Jul;18(7):962-73. doi: 10.1093/neuonc/nov321. Epub 2016 Jan 28.

50.

Intrinsic Astrocyte Heterogeneity Influences Tumor Growth in Glioma Mouse Models.

Irvin DM, McNeill RS, Bash RE, Miller CR.

Brain Pathol. 2017 Jan;27(1):36-50. doi: 10.1111/bpa.12348. Epub 2016 Apr 13.

Supplemental Content

Loading ...
Support Center